JP2024525150A5 - - Google Patents
Info
- Publication number
- JP2024525150A5 JP2024525150A5 JP2023577130A JP2023577130A JP2024525150A5 JP 2024525150 A5 JP2024525150 A5 JP 2024525150A5 JP 2023577130 A JP2023577130 A JP 2023577130A JP 2023577130 A JP2023577130 A JP 2023577130A JP 2024525150 A5 JP2024525150 A5 JP 2024525150A5
- Authority
- JP
- Japan
- Prior art keywords
- groups
- group
- unsubstituted
- substituted
- alkyloxyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21315095.6A EP4105218A1 (en) | 2021-06-15 | 2021-06-15 | Substituted pyrrolo[2,3-d] pyrimidines, their preparation and their therapeutic application |
| EP21315095.6 | 2021-06-15 | ||
| EP22315117.6 | 2022-06-02 | ||
| EP22315117 | 2022-06-02 | ||
| PCT/EP2022/066231 WO2022263472A1 (en) | 2021-06-15 | 2022-06-14 | Substituted pyrrolo[2,3-d]pyrimidines, their preparation and their therapeutic application |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024525150A JP2024525150A (ja) | 2024-07-10 |
| JP2024525150A5 true JP2024525150A5 (cg-RX-API-DMAC7.html) | 2025-06-12 |
| JP7886355B2 JP7886355B2 (ja) | 2026-07-07 |
Family
ID=82214141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577130A Active JP7886355B2 (ja) | 2021-06-15 | 2022-06-14 | 置換ピロロ[2,3-d]ピリミジン類、それらの製造及びそれらの治療適用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240383901A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4355748B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7886355B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240021910A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022294022A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023025042A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223786A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2024000083A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309195A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023015016A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022263472A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL330303A (en) * | 2023-12-27 | 2026-08-01 | Sanofi | Modified pyrrolo[2,3-d]pyrimidins, their preparation and therapeutic applications |
| KR20250163526A (ko) | 2024-05-14 | 2025-11-21 | 김성우 | 음전하 증폭장치가 장착된 어싱용 발판 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI398252B (zh) * | 2006-05-26 | 2013-06-11 | 諾華公司 | 吡咯并嘧啶化合物及其用途 |
| FR2988722B1 (fr) | 2012-04-03 | 2014-05-09 | Sanofi Sa | Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques |
| CN106146515B (zh) | 2015-04-17 | 2020-09-04 | 常州隆赛医药科技有限公司 | 新型激酶抑制剂的制备及应用 |
| US11214565B2 (en) | 2015-11-20 | 2022-01-04 | Denali Therapeutics Inc. | Compound, compositions, and methods |
| CN108934162A (zh) | 2015-12-16 | 2018-12-04 | 南方研究所 | 吡咯并嘧啶化合物、作为激酶lrrk2抑制剂的用途及其制备方法 |
| EP3587422A4 (en) | 2017-02-22 | 2020-05-06 | Daegu-Gyeongbuk Medical Innovation Foundation | PYRROLOPYRIMIDINE DERIVATIVE COMPOUND, PRODUCTION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION WITH THIS COMPOUND AS AN ACTIVE SUBSTANCE FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE |
| EP3873471B1 (en) | 2018-10-31 | 2025-12-31 | Merck Sharp & Dohme LLC | N-HETEROARYL INDAZOLE DERIVATIVES AS LRRK2 INHIBITORS: PHARMACEUTICAL COMPOSITIONS AND THEIR USES |
| EP3915985A4 (en) | 2019-01-18 | 2022-09-28 | Voronoi Co., Ltd. | PYRROLOPYRIDE DERIVATIVE AND USE THEREOF FOR THE PREVENTION AND TREATMENT OF PROTEIN KINASE RELATED DISEASES |
-
2022
- 2022-06-14 MX MX2023015016A patent/MX2023015016A/es unknown
- 2022-06-14 IL IL309195A patent/IL309195A/en unknown
- 2022-06-14 WO PCT/EP2022/066231 patent/WO2022263472A1/en not_active Ceased
- 2022-06-14 US US18/569,790 patent/US20240383901A1/en active Pending
- 2022-06-14 BR BR112023025042A patent/BR112023025042A2/pt unknown
- 2022-06-14 EP EP22733628.6A patent/EP4355748B1/en active Active
- 2022-06-14 JP JP2023577130A patent/JP7886355B2/ja active Active
- 2022-06-14 KR KR1020247001337A patent/KR20240021910A/ko active Pending
- 2022-06-14 CA CA3223786A patent/CA3223786A1/en active Pending
- 2022-06-14 AU AU2022294022A patent/AU2022294022A1/en active Pending
-
2024
- 2024-01-05 CO CONC2024/0000083A patent/CO2024000083A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107089985B (zh) | 作为詹纳斯相关激酶(jak)抑制剂的吡咯并[2,3-d]嘧啶衍生物 | |
| CN105669676B (zh) | 制备jak抑制剂及相关中间化合物的方法 | |
| US12624028B2 (en) | 1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) | |
| MD4800C1 (ro) | Compuşi de aminopirimidinil ca inhibitori de JAK | |
| JP2025521545A (ja) | 脊髄小脳失調症3型を処置するための化合物 | |
| EP3180344A1 (en) | Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase | |
| JP2013503191A (ja) | ヤヌスキナーゼインヒビターとしての複素環式化合物 | |
| US11273168B2 (en) | Methods of treating anxiety by administering a substituted quinolone | |
| JP7112755B2 (ja) | Jak酵素阻害剤及びその製造方法と用途 | |
| US20190211021A1 (en) | Preparation Method For Chiral Pyrrolopyrimidine Compound | |
| RS65308B1 (sr) | Biciklična ketonska jedinjenja i postupci za njihovu upotrebu | |
| JP2020536915A (ja) | Rip1キナーゼ阻害剤として使用するための二環式化合物 | |
| CN107667097B (zh) | 3-乙基双环[3.2.0]庚-3-烯-6-酮的对映体的分离 | |
| EP3704097A1 (en) | Bicyclic sulfones and sulfoxides and methods of use thereof | |
| JP2021100953A (ja) | ピリミジニルシクロペンタン化合物の調製方法 | |
| JP2017515845A5 (cg-RX-API-DMAC7.html) | ||
| WO2021084498A1 (en) | Fluorinated quinoline, quinoxaline and benzo[b][1,4]oxazine derivatives as dihydroorotate dehydrogenase (dhodh) inhibitors for the treatment of cancer, autoimmune and inflammatory diseases | |
| JP7688449B2 (ja) | ピリジン縮合環系化合物とその製造方法、中間体、組成物及び使用 | |
| JP2025506729A (ja) | チエノピロロトリアジン化合物、それらの調製及びそれらの治療的使用 | |
| WO2023001247A1 (zh) | 哒嗪酮类化合物 | |
| CN116425770A (zh) | 作为Cdc7抑制剂的四并环类化合物 | |
| US20240034739A1 (en) | Processes for making bicyclic ketone compounds | |
| TWI878888B (zh) | Ripk1抑制劑及使用方法 | |
| WO2013137479A1 (en) | Decahydroquinoxaline derivatives and analogs thereof | |
| RU2024100573A (ru) | Замещенные пирроло[2,3-d]пиримидины, их получение и их терапевтическое применение |